Department of Pharmaceutical Sciences, Tshwane University of Technology, Private Bag X680, Pretoria, 0001, South Africa.
Mar Drugs. 2010 Apr 19;8(4):1305-22. doi: 10.3390/md8041305.
Chitosan has been the subject of interest for its use as a polymeric drug carrier material in dosage form design due to its appealing properties such as biocompatibility, biodegradability, low toxicity and relatively low production cost from abundant natural sources. However, one drawback of using this natural polysaccharide in modified release dosage forms for oral administration is its fast dissolution rate in the stomach. Since chitosan is positively charged at low pH values (below its pK(a) value), it spontaneously associates with negatively charged polyions in solution to form polyelectrolyte complexes. These chitosan based polyelectrolyte complexes exhibit favourable physicochemical properties with preservation of chitosan's biocompatible characteristics. These complexes are therefore good candidate excipient materials for the design of different types of dosage forms. It is the aim of this review to describe complexation of chitosan with selected natural and synthetic polyanions and to indicate some of the factors that influence the formation and stability of these polyelectrolyte complexes. Furthermore, recent investigations into the use of these complexes as excipients in drug delivery systems such as nano- and microparticles, beads, fibers, sponges and matrix type tablets are briefly described.
壳聚糖由于其具有生物相容性、可生物降解性、低毒性和相对较低的生产成本等优点,已成为药物载体材料的研究热点。然而,将这种天然多糖用于口服的控释剂型时,其在胃中的溶解速度很快,这是一个缺点。由于壳聚糖在低 pH 值(低于其 pK(a) 值)下带正电荷,它会与溶液中的带负电荷的聚离子自发结合,形成聚电解质复合物。这些基于壳聚糖的聚电解质复合物具有良好的物理化学性质,并保留了壳聚糖的生物相容性特征。因此,这些复合物是设计不同类型剂型的理想赋形剂材料。本文旨在描述壳聚糖与选定的天然和合成聚阴离子的复合,并指出影响这些聚电解质复合物形成和稳定性的一些因素。此外,还简要描述了这些复合物作为纳米和微球、珠粒、纤维、海绵和基质型片剂等药物传递系统中的赋形剂的最新研究进展。
Curr Drug Deliv. 2007-10
Int J Biol Macromol. 2013-12-17
Carbohydr Polym. 2020-6-15
Carbon Lett (Korean Carbon Soc). 2022
Polymers (Basel). 2024-11-29
Front Pharmacol. 2024-8-5
Int J Nanomedicine. 2024
Indian J Pharm Sci. 2009-9
Adv Drug Deliv Rev. 2009-10-27
Adv Drug Deliv Rev. 2009-9-30
Molecules. 2009-7-16
Int J Pharm. 2009-4-15